Sean Khozin's guest appearances

Sean Khozin

Tech Tonics

Connected Social Media

Faces of Digital Health

Glen de Vries

Rasu Shrestha

Brennan Spiegel

Chris Johnson

Amy Brown

Richard Lee

Michelle Meyer

Brian Smith

Esther Wojcicki

Samson Williams

Tim Peck

Esther Dyson

Stephanie Tilenius

Richard Jacobs

Bill Rogers

OwlTail

Therapies for cancer are being developed at light speed and upward of 60 gene and cell therapies are projected to reach regulatory approval in the U.S. by 2030, according to the MIT NEWDIGS collaborative. Due to the nature of cancer, readiness for risks in drug development is much higher here than it might be in other medical fields. In this episode you’re going to hear a bit more about what can digital health innovation learn from the mindset present in oncology development. Sean Khozin is the CEO of CancerLinQ, a non-profit health technology company focused on improving quality of care and health outcomes for all patients with cancer. He was the Global Head of Data Strategy and Data Science Innovation at Johnson &amp; Johnson, before that he co-founded Hello Health, a technology company focused on developing integrated telemedicine, point-of-care data visualization, and advanced analytical systems for optimizing patient care and clinical research. He was also the Founding director of a digital health incubator inside the FDA. You will hear a little bit about processes in oncology, innovation in oncology, the promise of decentralized clinical trials and more.Leave a rating or review: lovethepodcast.com/facesofdigitalhealth

Therapies for cancer are being developed at light speed and upward of 60 gene and cell therapies are projected to reach regulatory approval in the <a href="https://newdigs.mit.edu/sites/default/files/NEWDIGS-Research-Brief-2020F207v51-PipelineAnalysis.pdf" rel="nofollow" target="_blank">U.S. by 2030, according to the MIT NEWDIGS collaborative. </a>Due to the nature of cancer, readiness for risks in drug development is much higher here than it might be in other medical fields. In this episode you’re going to hear a bit more about what can digital health innovation learn from the mindset present in oncology development. Sean Khozin is the CEO of <a href="https://www.cancerlinq.org/" rel="nofollow" target="_blank">CancerLinQ</a>, a non-profit health technology company focused on improving quality of care and health outcomes for all patients with cancer. He was the Global Head of Data Strategy and Data Science Innovation at Johnson &amp; Johnson, before that he co-founded Hello Health, a technology company focused on developing integrated telemedicine, point-of-care data visualization, and advanced analytical systems for optimizing patient care and clinical research. He was also the Founding director of a digital health incubator inside the FDA.  You will hear a little bit about processes in oncology, innovation in oncology, the promise of decentralized clinical trials and more. Leave a rating or review: <a href="http://lovethepodcast.com/facesofdigitalhealth" rel="nofollow" target="_blank">lovethepodcast.com/facesofdigitalhealth</a>

What Can Digital Health Innovators Learn from Oncology? (Sean Khozin)

After escaping the revolution in Iran, Sean Khozin found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&amp;J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s complicated” tends to be overused, but it hardly seems to do justice to Sean’s journey.  Sean was born in Tehran, a son sandwiched between two daughters.  Life for Sean’s family changed after the Revolution; the arrest of his dad, a political scientist, suggested it might be a good time to emigrate, which the entire family eventually did.  Sean, while in high school, initially went to live with relatives in Turkey, then came to the United States, where his family reunited in Maryland.   Sean completed high school in the US, and attended the University of Maryland, studying neurobiology and music theory, and traveling extensively on the side to NYC to pursue his passion for music composition and performance (especially classical guitar). After a pre-doctoral fellowship at the National Cancer Institute (NCI), and obtaining an MPH, Sean went to medical school, but was surprised by how unscientific so much of medicine was as compared to science.  After receiving his MD, he took at detour into entrepreneurship for several years, before being seduced back into medicine, completing a fellowship in oncology at the NCI, drawn by the promise he could pursue sophisticated analytics, inspired by the intellectual activity that was occurring in DC at the time, in particular the work of Todd Park and Aneesh Chopra. After his fellowship, Sean transitioned to the FDA, where he developed and championed the “INFORMED” initiative, which he’s described as “an incubator for driving innovations in agile technology, digital health, and data science to advance public health.”  Late last year, Sean left DC for J&amp;J, where he’s now head of data science strategy, and has the chance to work with some of the smartest and most decent people in the industry, including J&amp;J’s head of R&amp;D Mathai Mammen, (an MD/PhD classmate of David’s). Tech Tonics is grateful to Manatt Health for its sponsorship of the show.  Manatt Health is a multi-disciplinary professional services firm that includes a full service law firm and a broad-based strategic business and policy consulting practice to help clients grow and prosper.  Manatt Health supports the full range of stakeholders in transforming America’s healthcare system.

After escaping the revolution in Iran, <a href="https://www.seankhozin.com/" rel="noopener noreferrer nofollow" target="_blank">Sean Khozin</a> found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&amp;J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s complicated” tends to be overused, but it hardly seems to do justice to Sean’s journey.  Sean was born in Tehran, a son sandwiched between two daughters.  Life for Sean’s family changed after the Revolution; the arrest of his dad, a political scientist, suggested it might be a good time to emigrate, which the entire family eventually did.  Sean, while in high school, initially went to live with relatives in Turkey, then came to the United States, where his family reunited in Maryland.   Sean completed high school in the US, and attended the University of Maryland, studying neurobiology and music theory, and traveling extensively on the side to NYC to pursue his passion for music composition and performance (especially classical guitar). After a pre-doctoral fellowship at the National Cancer Institute (NCI), and obtaining an MPH, Sean went to medical school, but was surprised by how unscientific so much of medicine was as compared to science.  After receiving his MD, he took at detour into entrepreneurship for several years, before being seduced back into medicine, completing a fellowship in oncology at the NCI, drawn by the promise he could pursue sophisticated analytics, inspired by the intellectual activity that was occurring in DC at the time, in particular the work of Todd Park and Aneesh Chopra. After his fellowship, Sean transitioned to the FDA, where he developed and championed the “<a href="https://www.nature.com/articles/nrd.2018.34" rel="noopener noreferrer nofollow" target="_blank">INFORMED</a>” initiative, which he’s described as “an incubator for driving innovations in agile technology, digital health, and data science to advance public health.”  Late last year, Sean left DC for J&amp;J, where he’s now head of data science strategy, and has the chance to work with some of the smartest and most decent people in the industry, including J&amp;J’s head of R&amp;D <a href="https://www.forbes.com/sites/davidshaywitz/2016/03/03/mathai-mammen-the-anti-shkreli-brings-heart-and-a-touch-of-vagelos-to-merck-rd/" rel="noopener noreferrer nofollow" target="_blank">Mathai Mammen</a>, (an MD/PhD classmate of David’s). Tech Tonics is grateful to <a href="http://manatthealth.com/" rel="nofollow" target="_blank">Manatt Health</a> for its sponsorship of the show.  Manatt Health is a multi-disciplinary professional services firm that includes a full service law firm and a broad-based strategic business and policy consulting practice to help clients grow and prosper.  Manatt Health supports the full range of stakeholders in transforming America’s healthcare system.

Tech Tonics: Sean Khozin, Attuned To Data Science